옥시토신 시장 : 적응증별, 유통 채널별 - 세계 예측(2024-2032년)

Global Oxytocin Market size is projected to record 9.5% CAGR from 2024 to 2032, driven by the rapid growth of the geriatric population. Researchers are exploring expanded applications of oxytocin beyond conventional uses for enhancing social bonding and emotional well-being among older adults. With this ongoing exploration, oxytocin is playing a significant role in meeting the evolving needs of the aging society for offering new avenues for supporting elderly care and well-being.

The ongoing research is also driving the product application in geriatric healthcare for providing novel therapeutic approaches tailored to specific challenges of the aging population. According to the World Population Prospects 2022, the population above the age of 65 years is growing more rapidly than the population below that age. This trend is underscoring the increasing relevance of oxytocin research in addressing the specific needs of the aging demographic.

The overall market is segregated into indication, distribution channel, and region.

In terms of indication, the oxytocin industry from the antepartum segment is expected to record significant CAGR from 2024 to 2032, driven by the increasing role in preparing the body for childbirth. During pregnancy, the body naturally produces oxytocin to stimulate uterine contractions and facilitate labor. Hence, healthcare providers are using synthetic oxytocin to induce or augment labor when necessary. In addition, ongoing studies are trying to understand how oxytocin administration can be optimized to ensure safe and effective labor induction and management.

By distribution channel, the oxytocin industry from the online pharmacies segment is projected to rise from 2024 to 2032. Online pharmacies offer oxytocin for providing convenient access for patients seeking the hormone. These platforms are also supplying oxytocin for medical purposes, such as labor induction and management of postpartum hemorrhage. With technological advances, online pharmacies are improving healthcare accessibility, especially for medications like oxytocin that are critical in maternal and reproductive health.

Regionally, the Asia Pacific oxytocin market size is projected to exhibit robust growth between 2024 and 2032, fueled by the expanding applications in assisted reproduction and advancements in drug delivery methods. Healthcare providers in the region are utilizing oxytocin to enhance outcomes in fertility treatments and manage labor effectively. The ongoing advancements in drug delivery technologies for optimizing the administration of oxytocin for improving its efficacy and safety profiles in reproductive health care will drive the product uptake in APAC.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Rising incidence of pregnancy complications
  • 3.2.3 Increase in childbirth rates
  • 3.2.4 Growing awareness of induced labor and breastfeeding
  • 3.2.5 Increasing research & development activities
  • 3.2.6 Industry pitfalls & challenges
  • 3.2.7 Stringent regulatory requirements
  • 3.2.8 High cost of drug
• 3.3 Growth potential analysis
• 3.4 Pipeline analysis
• 3.5 Regulatory landscape
• 3.6 Technological landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Antepartum
• 5.3 Postpartum

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Hospital pharmacies
• 6.3 Retail pharmacies
• 6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
  • 7.3.7 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 Endo International plc
• 8.2 Ferring Pharmaceuticals
• 8.3 Fresenius SE & Co. KGaA
• 8.4 Hikma Pharmaceuticals PLC
• 8.5 Novartis AG
• 8.6 Pfizer Inc.
• 8.7 Sun Pharma Industries Limited.
• 8.8 Teva Pharmaceutical Industries Ltd.
• 8.9 Viatris Inc.
• 8.10 Wockhardt Limited
• 8.11 Yuhan Corporation